# Pillar5 Pharma Inc. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/pillar5-pharma-inc/8b94b834-f2da-4821-9ddc-6795a5e6d6f0

> Inspection records and compliance data for Pillar5 Pharma Inc. in Arnprior, None. Access full analysis and detailed observations.

---

## Details

- Name: Pillar5 Pharma Inc.
- FEI Number: 3000241849
- Canada Business Number: 837344662
- City: Arnprior
- State: None
- Country Name: Canada
- Address Line 1: 365 Madawaska Blvd,
- Zip Code: None

## Related Documents

- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #87850 - 2025-12-02](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/6036db5f-3dcd-4ce5-95d2-0189f9f86208) — source: Canada, date: December 2, 2025
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #87849 - 2025-12-02](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/3cb613f8-5c6b-4756-89c9-827ded5e86d6) — source: Canada, date: December 2, 2025
- [483 - Pillar5 Pharma Inc. - 2025-02-07](https://www.globalkeysolutions.net/records/483/pillar5-pharma-inc/aae128df-7323-4546-9ab7-cb02e0d26682) — source: FDA, date: February 7, 2025
- [FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/e135bdf9-ed1a-4ef9-8d9c-e584d1d5e5ab) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/9bde498e-2566-4025-8c5b-53bacfb5ac30) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/4d585495-e870-4a98-bc55-0302c9f96034) — source: FDA, date: February 7, 2025
- [FDA Inspection 1261773 - Pillar5 Pharma Inc. - 2025-02-07](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/75315d01-02ba-4fbf-b73a-07cff71e8be9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2025
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #82704 - 2024-01-29](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/80b423c0-f92b-4490-8a89-add228caae6d) — source: Canada, date: January 29, 2024
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #82703 - 2024-01-29](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/8e7520aa-023c-4ac9-9c6e-ba5f407acd22) — source: Canada, date: January 29, 2024
- [483 - Pillar5 Pharma Inc. - 2023-12-15](https://www.globalkeysolutions.net/records/483/pillar5-pharma-inc/49d12328-3ebf-4ca3-ade2-5b08703919fb) — source: FDA, date: December 15, 2023
- [FDA Inspection 1226692 - Pillar5 Pharma Inc. - 2023-12-15](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/1c30bf78-de6b-4e30-9cd1-131e956f9474) — classification: No Action Indicated (NAI), source: FDA, date: December 15, 2023
- [FDA Inspection 1226692 - Pillar5 Pharma Inc. - 2023-12-15](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/d18f4f76-6e8e-4741-826d-9fbbd52772fb) — classification: Official Action Indicated (OAI), source: FDA, date: December 15, 2023
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #81067 - 2023-06-28](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/bced174a-bd05-4c75-b108-286196c75f5a) — source: Canada, date: June 28, 2023
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #78409 - 2022-03-21](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/38dd8c29-a276-465a-ac59-9bb10adcb073) — source: Canada, date: March 21, 2022
- [483 - Pillar5 Pharma Inc. - 2020-02-21](https://www.globalkeysolutions.net/records/483/pillar5-pharma-inc/3fef87a0-f16d-4de4-bd43-7132bce6c38f) — source: FDA, date: February 21, 2020
- [FDA Inspection 1119040 - Pillar5 Pharma Inc. - 2020-02-21](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/d4a5d5a4-623d-486d-abe2-139b9e57a089) — classification: No Action Indicated (NAI), source: FDA, date: February 21, 2020
- [FDA Inspection 1119040 - Pillar5 Pharma Inc. - 2020-02-21](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/eca79219-f953-4c03-9d4e-3e911728bcdb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 21, 2020
- [Canada Inspection - Pillar5 Pharma Inc. - Inspection #72596 - 2019-10-30](https://www.globalkeysolutions.net/records/canada_inspection/pillar5-pharma-inc/ded5c606-5845-4668-80f2-965b85cb9bcd) — source: Canada, date: October 30, 2019
- [FDA Inspection 1058599 - Pillar5 Pharma Inc. - 2018-05-17](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/8d2cb669-148c-433d-a6ac-1c3212b195d7) — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2018
- [FDA Inspection 1038745 - Pillar5 Pharma Inc. - 2018-01-26](https://www.globalkeysolutions.net/records/fda_inspections/pillar5-pharma-inc/af92adfa-2871-4c3f-927c-7ef4addb9368) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 26, 2018

## Related Companies

- [Groupe Parima Inc.](https://www.globalkeysolutions.net/companies/groupe-parima-inc/49e213ea-3ec6-4535-adaf-c0b6c7d25a23)
- [Vetio Animal Health](https://www.globalkeysolutions.net/companies/vetio-animal-health/7b019ca7-7830-408c-a1f0-bc4a533fd9a4)
- [Labomar Canada Inc](https://www.globalkeysolutions.net/companies/labomar-canada-inc/1c212e6b-5d3d-4379-af67-cf8fde6c6aa4)
- [Cosmetica Laboratories Inc.](https://www.globalkeysolutions.net/companies/cosmetica-laboratories-inc/bcfa9f67-ec98-41ed-a67f-62ff5060c0be)
- [Contract Pharmaceuticals Limited Canada](https://www.globalkeysolutions.net/companies/contract-pharmaceuticals-limited-canada/02ec2d1f-df8d-4636-95d2-b548aea571d8)
- [Kenvue Canada Inc.](https://www.globalkeysolutions.net/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)
- [G Production, Inc.](https://www.globalkeysolutions.net/companies/g-production-inc/e4d0a8bc-be0e-45a9-99e4-0e882671d7f7)
- [E-Z-EM Canada, Inc](https://www.globalkeysolutions.net/companies/e-z-em-canada-inc/de31e064-9679-4127-b65f-39ecba03c801)
- [Viva Pharmaceutical Inc](https://www.globalkeysolutions.net/companies/viva-pharmaceutical-inc/0e5d1aa3-8369-4a0d-91b7-e516415fb219)
- [Duchesnay Inc.](https://www.globalkeysolutions.net/companies/duchesnay-inc/b48797ea-bce2-4e75-a2cd-4e6b3a5f722c)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/sarah-e-rhoades/d965990c-15cc-4722-b2d0-aea7206c71b0)
- [Drug Specialist  / Drug Investigator](https://www.globalkeysolutions.net/people/saundrea-a-munroe/129a869f-e1f2-4d59-b3ed-9613a9190f8a)
- [Investigator](https://www.globalkeysolutions.net/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)
- [Miguel A. Martinez](https://www.globalkeysolutions.net/people/miguel-a-martinez/62e722b2-30bd-4671-9db9-8f089093e5a5)